Statement 19 March 2020

Global Biopharmaceutical Industry Commitment to Address Coronavirus Public Health Crisis


As part of the global health community, biopharmaceutical companies are committed to playing the greatest possible role in the global response to COVID-19.

Our members have a breadth of expertise (research, clinical development, manufacturing) that uniquely positions our industry to support the fight against the spread of COVID-19. We have a strong sense of responsibility to act together, as well as in partnership with the World Health Organization (WHO), governments and health systems across the world in a concerted, collective response.

Already, our industry has responded on an unprecedented scale to the current pandemic.

Download this statement to see the 7 commitments the industry is making to address the Coronavirus public health crisis.


The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations around the world. Our industry’s almost three million employees discover, develop, and deliver medicines and vaccines that advance global health. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. For more information, visit

Learn more

Media Contact

Elliot Dunster